These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

411 related articles for article (PubMed ID: 2955066)

  • 1. Receptor antagonist of platelet activating factor inhibits inflammatory injury induced by in situ formation of immune complexes in renal glomeruli and in the skin.
    Camussi G; Pawlowski I; Saunders R; Brentjens J; Andres G
    J Lab Clin Med; 1987 Aug; 110(2):196-206. PubMed ID: 2955066
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of platelet-activating factor and its specific receptor antagonist on glomerular permeability to proteins in isolated perfused rat kidney.
    Perico N; Delaini F; Tagliaferri M; Abbate M; Cucchi M; Bertani T; Remuzzi G
    Lab Invest; 1988 Feb; 58(2):163-71. PubMed ID: 3123798
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Experimental glomerulonephritis in the isolated perfused rat kidney.
    Couser WG; Steinmuller DR; Stilmant MM; Salant DJ; Lowenstein LM
    J Clin Invest; 1978 Dec; 62(6):1275-87. PubMed ID: 372233
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nephritogenic potential of sheep antibodies against glomerular basement membrane laminin in the rat.
    Feintzeig ID; Abrahamson DR; Cybulsky AV; Dittmer JE; Salant DJ
    Lab Invest; 1986 May; 54(5):531-42. PubMed ID: 3517487
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanism of formation of subepithelial electron-dense deposits in active in situ immune complex glomerulonephritis.
    Kagami S; Kawakami K; Okada K; Kuroda Y; Morioka T; Shimizu F; Oite T
    Am J Pathol; 1990 Mar; 136(3):631-9. PubMed ID: 1690511
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mediator systems in a passive model of in situ immune complex glomerulonephritis. Role for complement, polymorphonuclear granulocytes and monocytes.
    Thaiss F; Batsford S; Mihatsch MJ; Heitz PU; Bitter-Suermann D; Vogt A
    Lab Invest; 1986 Jun; 54(6):624-35. PubMed ID: 2940417
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interaction of antibodies with human glomerular epithelial cells.
    Fukatsu A; Yuzawa Y; Olson L; Miller J; Milgrom M; Zamlauski-Tucker MJ; Van Liew JB; Campagnari A; Niesen N; Patel J
    Lab Invest; 1989 Oct; 61(4):389-403. PubMed ID: 2796288
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glomerular injury induced by cationic 70-kD staphylococcal protein; specific immune response is not involved in early phase in rats.
    Fujigaki Y; Yousif Y; Morioka T; Batsford S; Vogt A; Hishida A; Miyasaka M
    J Pathol; 1998 Apr; 184(4):436-45. PubMed ID: 9664912
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of aminonucleoside nephrosis on immune complex localization in autologous immune complex nephropathy in rats.
    Couser WG; Jermanovich NB; Belok S; Stilmant MM; Hoyer JR
    J Clin Invest; 1978 Mar; 61(3):561-72. PubMed ID: 147884
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mesangial disposal of glomerular immune deposits in acute malarial glomerulonephritis of rats.
    Sterzel RB; Ehrich JH; Lucia H; Thomson D; Kashgarian M
    Lab Invest; 1982 Feb; 46(2):209-14. PubMed ID: 7038293
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathogenesis of passive Heymann glomerulonephritis: chlorpromazine inhibits antibody-mediated redistribution of cell surface antigens and prevents development of the disease.
    Camussi G; Noble B; Van Liew J; Brentjens JR; Andres G
    J Immunol; 1986 Mar; 136(6):2127-35. PubMed ID: 3485141
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Progressive passive Heymann nephritis in the rat.
    Barabas AZ; Boyd N; Cornish J; Lannigan R
    Lab Invest; 1982 Oct; 47(4):400-5. PubMed ID: 6214666
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rat bovine serum albumin (BSA) nephritis. VI. The influence of chemically altered antigen.
    Yamamoto T; Miyazaki S; Kawasaki K; Yaoita E; Kihara I
    Clin Exp Immunol; 1986 Jul; 65(1):51-6. PubMed ID: 3539427
    [TBL] [Abstract][Full Text] [Related]  

  • 14. C3 dependent, C5 independent immune complex glomerulopathy in the mouse.
    Sawtell NM; Hartman AL; Weiss MA; Pesce AJ; Michael JG
    Lab Invest; 1988 Mar; 58(3):287-93. PubMed ID: 2964544
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of cyclosporine on in situ immune complex glomerulonephritis.
    Thaiss F; Mihatsch MJ; Batsford S; Vogt A; Schollmeyer P
    Clin Nephrol; 1986; 25 Suppl 1():S181-5. PubMed ID: 3519025
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Experimental glomerulonephritis in the mouse associated with mesangial deposition ofautologous ferritin immune complexes.
    Stilmant MM; Couser WG; Cotran RS
    Lab Invest; 1975 Jun; 32(6):746-56. PubMed ID: 125361
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mesangial glomerulonephropathy with deposition of IgG, IgM, and C3 induced by mercuric chloride: a new model.
    Makker SP; Aikawa M
    Lab Invest; 1979 Jul; 41(1):45-50. PubMed ID: 376939
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Receptor antagonists of platelet-activating factor do not influence the development of passive Heymann nephritis.
    Salvidio G; Brentjens J; Camussi G
    J Lipid Mediat; 1991; 3(2):197-204. PubMed ID: 1665716
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An active model of immune complex glomerulonephritis in the rat employing cationized antigen.
    Oite T; Shimizu F; Kihara I; Batsford SR; Vogt A
    Am J Pathol; 1983 Aug; 112(2):185-94. PubMed ID: 6224427
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immune adherence in renal glomeruli. Complement receptor sites on glomerular capillary epithelial cells.
    Burkholder PM; Oberley TD; Barber TA; Beacom A; Koehler C
    Am J Pathol; 1977 Mar; 86(3):635-54. PubMed ID: 842614
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.